Cobram Estate Olives (CBO) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
23 Jan, 2026Executive summary
Achieved record sales growth, with olive oil sales revenue reaching AUD 220.9 million, up 134.6% year-over-year, and net profit after tax of AUD 18.5 million, up 140.1% from FY2023.
EBITDA rose 163.4% to AUD 66.7 million, driven by strong sales in Australia and the USA, improved product mix, and higher average prices.
Record operating cash flow of AUD 64.1 million, up 18.4% year-over-year.
Maintained market leadership in Australia, with a combined 37.9% value share for Cobram Estate® and Red Island®.
Continued investment in growth assets and sustainability initiatives in both Australia and the USA, positioning for future expansion.
Financial highlights
Australian packaged goods sales increased 28.1% to AUD 142.9 million; USA packaged goods sales surged 78.9% to AUD 50.5 million.
EBITDA in Australia reached AUD 60.1 million; U.S. EBITDA grew to AUD 5.8 million from AUD 2.9 million.
Net assets increased from AUD 287 million to AUD 322 million.
Adjusted asset value (including trees and irrigation infrastructure) rose to AUD 845 million from AUD 718 million.
Net debt ratio increased to 31.5% from 29.8% as of June 30, 2024.
Outlook and guidance
FY2025 is an "on-year" for Australian groves; EBITDA expected to be materially higher, subject to agricultural risks.
Operating cash flow projected to remain strong, fully funding planned U.S. expansion.
Australian CapEx to shift toward maintenance, with U.S. growth projects prioritized.
15% price increase in the USA effective September 2024.
Board anticipates a fully franked dividend of 3.3 cents per share in December 2024.
Latest events from Cobram Estate Olives
- EBITDA beat guidance, losses widened, but capital raising supports U.S. expansion and brand growth.CBO
H1 202620 Feb 2026 - Record profits, U.S.A. expansion, and sustainability drive future growth and shareholder returns.CBO
AGM 20243 Feb 2026 - Sales and EBITDA surged, losses narrowed, and U.S. expansion plus a larger crop drive strong outlook.CBO
H1 202523 Dec 2025 - Record profit and sales growth, U.S. expansion, and robust outlook define the year.CBO
H2 202523 Nov 2025 - Record profit, U.S. expansion, and sustainability drive long-term growth and shareholder value.CBO
AGM 202513 Nov 2025 - Major capital raise to fund rapid USA expansion, targeting 3,600 hectares and 9M+ litres of oil.CBO
Investor Presentation9 Sep 2025